Evidence map›Paper›PMID 31591402›Full record

ArticleNature communications2019

Galactose to tagatose isomerization at moderate temperatures with high conversion and productivity.

Josef R Bober, Nikhil U Nair

Abstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Engineering ofCurrent research in food science · 2026
    Article
  3. Article
  4. Activating the d-Tagatose Production Capacity ofJournal of agricultural and food chemistry · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Sustainable isomaltulose production inFrontiers in microbiology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Cell Wall Anchoring of a Bacterial Chitosanase inInternational journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Josef R BoberDepartment of Chemical and Biological Engineering, Tuts University, Medford, MA, 02155, USA.
Nikhil U NairDepartment of Chemical and Biological Engineering, Tuts University, Medford, MA, 02155, USA. nikhil.nair@tufts.edu.ORCID http://orcid.org/0000-0001-7737-1385

Funding

Metabolic engineering in humans: Altered gut microbes as a therapeutic platformDP2HD091798 · NICHD · TUFTS UNIVERSITY MEDFORD · PI NAIR, NIKHIL UNNI · 2016 to 2016
$2.3M
Toward Altered Probiotic Therapy for PhenylketonuriaR03HD090444 · NICHD · TUFTS UNIVERSITY MEDFORD · PI NAIR, NIKHIL UNNI · 2017 to 2018
$144k
NICHD NIH HHS DP2 HD091798NICHD NIH HHS R03 HD090444
6 · The paper itself

Abstract

There are many industrially-relevant enzymes that while active, are severely limited by thermodynamic, kinetic, or stability issues (isomerases, lyases, transglycosidases). In this work, we study Lactobacillus sakei L-arabinose isomerase (LsLAI) for D-galactose to D-tagatose isomerization-that is limited by all three reaction parameters. The enzyme demonstrates low catalytic efficiency, low thermostability at temperatures > 40 °C, and equilibrium conversion < 50%. After exploring several strategies to overcome these limitations, we show that encapsulating LsLAI in gram-positive Lactobacillus plantarum that is chemically permeabilized enables reactions at high rates, high conversions, and elevated temperatures. In a batch process, this system enables ~ 50% conversion in 4 h starting with 300 mM galactose (an average productivity of 37 mM h

Indexed as

Aldose-Ketose IsomerasesBacterial ProteinsBiocatalysisEnzyme StabilityGalactoseHexosesHydrogen-Ion ConcentrationIsomerismKineticsLactiplantibacillus plantarumTemperatureAldose-Ketose IsomerasesBacterial ProteinsD-arabinose isomeraseGalactoseHexosestagatose

Identifiers

PMID31591402
PMCPMC6779876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.